BioSpace News Archive

Partnership for Drug-Free Kids, the nation’s leading nonprofit committed to helping families struggling with their son’s or daughter’s substance use, today announced that it has extended the hours of its free Parent Helpline.

The replacement of animals as test subjects is one step closer to reality with the successful testing of multi-organ “human-on-a-chip” models to recapitulate the 28 day experiments typically used in animals to evaluate the systemic toxicity of drug and cosmetic compounds.

Intec Pharma Ltd. (NASDAQ: NTEC) (“Intec” or “the Company”) today announces that Jeffrey A. Meckler, Vice Chairman and Chief Executive Officer of Intec Pharma, has issued a Letter to Shareholders, the full text of which follows below.

MFG Chemical, a global leader in specialty and custom chemical manufacturing, is announcing the promotion of Barry Lassiter to VP Operations, responsible for MFG’s three plants in the Dalton, GA area and the recently acquired 26.7 acre plant in Pasadena, TX.

Haemonetics Announces Headquarters Relocation To Boston, issued 19-Dec-2018 by Haemonetics Corporation over PR Newswire, we are advised by the company that the third paragraph, first sentence, should read “17-acre campus” rather than “40-acre campus” as originally issued inadvertently.

Tivity Health, Inc. (NASDAQ: TVTY) will present at the 37th Annual J.P. Morgan Healthcare Conference to be held January 7-10, 2019 in San Francisco, CA.

Inscripta™, a leading gene-editing technology company, today announced that MAD7, its proprietary CRISPR enzyme, has achieved wide adoption by academic, commercial, and government researchers in its first year of availability.

Centinel Spine Inc.® the largest privately-held spine company focused on anterior column reconstruction, announces the 10th anniversary celebration of its founding.

Cantel Medical Corporation (NYSE: CMD) announced today that its Board of Directors approved an increase in its semiannual cash dividend from $0.085 to $0.10 per outstanding share of the Company’s Common Stock.

- VIVA Physicians will host a special session of its Vascular Leaders Forum series, “Drug Elution in Peripheral Artery Disease (PAD): A Critical Analysis from a Multispecialty Consortium”, February 28-March 1, 2019, in Washington, DC, at the Kimpton Hotel Palomar Washington DC, located at 2121 P Street NW, Washington DC.